Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 6,153 shares at $34.35 ($211K) on 2026-06-05, disclosed to the SEC on 2026-06-08.
Scheduled sale ($211k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |
| TEVA | SELL | 2025-03-06 | $751K | — | Filing → |